| Dr Amy Rebekah Benson, MD | |
|
2935 Sw Cedar Hills Blvd, Beaverton, OR 97005-1342 | |
| (503) 352-6000 | |
| Not Available |
| Full Name | Dr Amy Rebekah Benson |
|---|---|
| Gender | Female |
| Speciality | Pediatrics |
| Location | 2935 Sw Cedar Hills Blvd, Beaverton, Oregon |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1487790184 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | MD150140 (Oregon) | Primary |
| Entity Name | Multnomah County |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609914787 PECOS PAC ID: 6608771787 Enrollment ID: O20031203000025 |
News Archive
Results of an important new study show that implantation of blue light-filtering intraocular lens (IOLs) at the time of cataract surgery increases a nutritional component of the eye, which may afford protection against the development and/or progression of age-related macular degeneration (AMD).
The National Community Pharmacists Association is pressuring Medicare officials to delay a regulation that they say will drive up labor costs for drug stores and increase the potential for dispensing errors. The proposed rule is expected to be finalized and take effect on Jan. 1, 2012.
An integrated approach that unifies psychosocial factors with neurobiology sheds light on chronic pain traits and their underlying brain networks, according to a study published August 20 in the open-access journal PLOS Biology by A. Vania Apkarian of Northwestern University Feinberg School of Medicine, and colleagues.
BIND Therapeutics, a clinical-stage biopharmaceutical company developing a new class of highly selective targeted and programmable therapeutics called Accurins, announced today that it has entered into a global collaboration agreement with Pfizer Inc. to develop and commercialize Accurins utilizing select small molecule targeted therapies.
Work is causing stress for more Seattleites this year according to the American Psychological Association's (APA) Stress in America survey, while the number reporting money or the economy as significant stressors has dropped since last year. More than 50 percent of city residents remain stressed by one or more of these three sources, a cause of concern for psychologists who worry about the effects of long-term stress and how it can contribute to chronic health disorders.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Amy Rebekah Benson, MD 2935 Sw Cedar Hills Blvd, Beaverton, OR 97005-1342 Ph: (503) 352-6028 | Dr Amy Rebekah Benson, MD 2935 Sw Cedar Hills Blvd, Beaverton, OR 97005-1342 Ph: (503) 352-6000 |
News Archive
Results of an important new study show that implantation of blue light-filtering intraocular lens (IOLs) at the time of cataract surgery increases a nutritional component of the eye, which may afford protection against the development and/or progression of age-related macular degeneration (AMD).
The National Community Pharmacists Association is pressuring Medicare officials to delay a regulation that they say will drive up labor costs for drug stores and increase the potential for dispensing errors. The proposed rule is expected to be finalized and take effect on Jan. 1, 2012.
An integrated approach that unifies psychosocial factors with neurobiology sheds light on chronic pain traits and their underlying brain networks, according to a study published August 20 in the open-access journal PLOS Biology by A. Vania Apkarian of Northwestern University Feinberg School of Medicine, and colleagues.
BIND Therapeutics, a clinical-stage biopharmaceutical company developing a new class of highly selective targeted and programmable therapeutics called Accurins, announced today that it has entered into a global collaboration agreement with Pfizer Inc. to develop and commercialize Accurins utilizing select small molecule targeted therapies.
Work is causing stress for more Seattleites this year according to the American Psychological Association's (APA) Stress in America survey, while the number reporting money or the economy as significant stressors has dropped since last year. More than 50 percent of city residents remain stressed by one or more of these three sources, a cause of concern for psychologists who worry about the effects of long-term stress and how it can contribute to chronic health disorders.
› Verified 8 days ago
Douglas Joseph Hamill, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 4855 Sw Western Ave, Beaverton Medical Office, Beaverton, OR 97005 Phone: 503-643-7565 | |
Dr. Luanne Nilsen, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 4855 Sw Western Ave, Beaverton, OR 97005 Phone: 503-643-7565 | |
Dean A Moshofsky, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 15455 Nw Greenbrier Pkwy, Ste 111, Beaverton, OR 97006 Phone: 503-534-3434 Fax: 503-645-4544 | |
Heather M Moore, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 15455 Nw Greenbrier Pkwy, Ste 111, Beaverton, OR 97006 Phone: 503-531-3434 Fax: 503-645-4544 | |
Thomas Jeffrey Anderson Ii, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 15455 Nw Greenbrier Pkwy Ste 111, Beaverton, OR 97006 Phone: 503-531-3434 Fax: 503-645-4544 | |
Cole Julius Nygard, Pediatrics Medicare: Medicare Enrolled Practice Location: 15455 Nw Greenbrier Pkwy Ste 111, Beaverton, OR 97006 Phone: 503-531-3434 | |
Mary Ellen Ulmer, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 15950 Sw Millikan Way, Beaverton, OR 97006 Phone: 503-646-0161 Fax: 503-643-7459 |